NPM1 Gene Expression as a Molecular Prognostic Marker in Acute Myeloid Leukemia Among Egyptian Patients
abdelrahman, A., hablas, A., naser, G., hassan, A., badr, E., Abuelela, S., ismail, H. (2025). NPM1 Gene Expression as a Molecular Prognostic Marker in Acute Myeloid Leukemia Among Egyptian Patients. EKB Journal Management System, 11(1), 22-32. doi: 10.21608/rjab.2024.323687.1057
abdelrahman abdelrahman; ahmed hablas; ghada naser; asmaa hassan; eman badr; Soha Abuelela; hisham ismail. "NPM1 Gene Expression as a Molecular Prognostic Marker in Acute Myeloid Leukemia Among Egyptian Patients". EKB Journal Management System, 11, 1, 2025, 22-32. doi: 10.21608/rjab.2024.323687.1057
abdelrahman, A., hablas, A., naser, G., hassan, A., badr, E., Abuelela, S., ismail, H. (2025). 'NPM1 Gene Expression as a Molecular Prognostic Marker in Acute Myeloid Leukemia Among Egyptian Patients', EKB Journal Management System, 11(1), pp. 22-32. doi: 10.21608/rjab.2024.323687.1057
abdelrahman, A., hablas, A., naser, G., hassan, A., badr, E., Abuelela, S., ismail, H. NPM1 Gene Expression as a Molecular Prognostic Marker in Acute Myeloid Leukemia Among Egyptian Patients. EKB Journal Management System, 2025; 11(1): 22-32. doi: 10.21608/rjab.2024.323687.1057

NPM1 Gene Expression as a Molecular Prognostic Marker in Acute Myeloid Leukemia Among Egyptian Patients

Research Journal of Applied Biotechnology
Article 3, Volume 11, Issue 1, June 2025, Page 22-32  XML PDF (499.7 K)
Document Type: Original Article
DOI: 10.21608/rjab.2024.323687.1057
View on SCiNiTO View on SCiNiTO
Authors
abdelrahman abdelrahman1; ahmed hablas email 2; ghada naser1; asmaa hassan3; eman badr4; Soha Abuelela5; hisham ismail1
1Molecular Diagnostics and Therapeutics Dept., Genetic Engineering and Biotechnology Research Institute, University of Sadat City.
2Molecular Diagnostics and Therapeutics Dept., Genetic Engineering and Biotechnology Research Institute, University of Sadat City, and Clinical Pathology Dept., Faculty of Medicine, Kafr El-Sheikh University, Kafr El-Sheikh, Egypt.
3Clinical Pathology Dept., Faculty of Medicine, Kafr El-Sheikh University, Kafr El-Sheikh, Egypt.
43Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia University, Shibīn al-Koum 32511, Egypt.
5Clinical Pathology Dept., Faculty of Medicine, Ain Shams University, Egypt.
Abstract
Background and objectives: Acute myeloid leukemia is the most prevalent type of leukemia in adults. It is defined by changes in average hematopoietic growth and differentiation, resulting in large numbers of abnormal, immature myeloid cells in the bone marrow and peripheral blood. This study aimed to investigate the Neucleophosmin1 mutation gene by detecting the Neucleophosmin1 subtypes (A, B, C, D, and P) and their correlation to other clinical and pathological parameters.
Methods: This study involved 150 subjects: 100 newly diagnosed cases with acute myeloid leukemia and 50 age and gender-matched controls. Neucleophosmin1 gene mutation subtypes were detected by real-time polymerase chain reaction.
Results: Mutation D was linked to a markedly lower survival rate among the acute myeloid leukemia mutated Neucleophosmin1 cases and was correlated with other prognostic indicators (high blast count and M1 in French, American, British). Cytogenetic normality was more significant with mutation A than with other different mutations.
Conclusion: This study concluded that Neucleophosmin1 gene mutation subtypes showed different prognostic significance and overall survival, suggesting that Neucleophosmin1 gene mutation subtype analysis is recommended as a prognostic marker in acute myeloid leukemia. 
Keywords
AML; NPM1 mutation; NPM1 subtype; PCR
Statistics
Article View: 1,189
PDF Download: 132